Skip to main content
EJNMMI Research
Fig. 3 | EJNMMI Research

Fig. 3

From: A comparison of FLT to FDG PET/CT in the early assessment of chemotherapy response in stages IB–IIIA resectable NSCLC

Fig. 3

Line graphs showing FDG SULmax and FLT SULmax at baseline (B), post-cycle 1 (PC1), and post-cycle 2 (PC2). In responding patients (highlighted in green), FDG SULmax decreased significantly more from baseline to post-cycle 1 than in non-responding patients (P = 0.017). FLT SULmax did not differ significantly between responders and non-responders (P = 0.336) from baseline to post-cycle 1

Back to article page